de Beukelaar et al., 2007 - Google Patents
The impact of impurities in synthetic peptides on the outcome of T‐cell stimulation assaysde Beukelaar et al., 2007
View PDF- Document ID
- 13335937358419831611
- Author
- de Beukelaar J
- Gratama J
- Smitt P
- Verjans G
- Kraan J
- Luider T
- Burgers P
- Publication year
- Publication venue
- Rapid Communications in Mass Spectrometry: An International Journal Devoted to the Rapid Dissemination of Up‐to‐the‐Minute Research in Mass Spectrometry
External Links
Snippet
Protein‐spanning peptide pools have proven valuable as a screening tool for detecting T‐ lymphocyte responses against a wide range of proteins. We have used this approach in our search for T cells reactive to the onconeural protein HuD. We found positive responses in …
- 102000004196 processed proteins & peptides 0 title abstract description 72
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6848—Methods of protein analysis involving mass spectrometry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/62—Detectors specially adapted therefor
-
- H—ELECTRICITY
- H01—BASIC ELECTRIC ELEMENTS
- H01J—ELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS
- H01J49/00—Particle spectrometer or separator tubes
- H01J49/004—Combinations of spectrometers, tandem spectrometers, e.g. MS/MS, MSn
- H01J49/0045—Combinations of spectrometers, tandem spectrometers, e.g. MS/MS, MSn characterised by the fragmentation or other specific reaction
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means
- G01N27/62—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means by investigating the ionisation of gases; by investigating electric discharges, e.g. emission of cathode
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Reid et al. | ‘Top down’protein characterization via tandem mass spectrometry | |
McAlister et al. | MultiNotch MS3 enables accurate, sensitive, and multiplexed detection of differential expression across cancer cell line proteomes | |
Lermyte et al. | Electron transfer dissociation provides higher‐order structural information of native and partially unfolded protein complexes | |
Brodbelt | Ion activation methods for peptides and proteins | |
Hardouin | Protein sequence information by matrix‐assisted laser desorption/ionization in‐source decay mass spectrometry | |
Steen et al. | Quadrupole time‐of‐flight versus triple‐quadrupole mass spectrometry for the determination of phosphopeptides by precursor ion scanning | |
Kjeldsen et al. | Cα C Backbone Fragmentation Dominates in Electron Detachment Dissociation of Gas‐Phase Polypeptide Polyanions | |
Che et al. | Quantitative peptidomics of mouse pituitary: comparison of different stable isotopic tags | |
Segu et al. | Characterizing protein glycosylation sites through higher‐energy C‐trap dissociation | |
Fuchs et al. | Proteomics in nutrition research: principles, technologies and applications | |
Chen et al. | Identification of MHC peptides using mass spectrometry for neoantigen discovery and cancer vaccine development | |
Canterbury et al. | Assessing the dynamic range and peak capacity of nanoflow LC− FAIMS− MS on an ion trap mass spectrometer for proteomics | |
Shvartsburg et al. | Separation of peptide isomers with variant modified sites by high-resolution differential ion mobility spectrometry | |
Ibrahim et al. | Ultrasensitive identification of localization variants of modified peptides using ion mobility spectrometry | |
JP2009538430A (en) | Quantifying expression using mass spectrometry | |
Muntel et al. | An exclusion list based label‐free proteome quantification approach using an LTQ Orbitrap | |
Erba | Investigating macromolecular complexes using top‐down mass spectrometry | |
Debois et al. | MALDI in-source decay, from sequencing to imaging | |
Gu et al. | Use of deuterium-labeled lysine for efficient protein identification and peptide de novo sequencing | |
JP2007538262A (en) | Quantifying expression using mass spectrometry | |
Stiving et al. | Coupling 193 nm ultraviolet Photodissociation and ion mobility for sequence characterization of Conformationally-selected peptides | |
Lau et al. | Observations on the detection of b‐and y‐type ions in the collisionally activated decomposition spectra of protonated peptides | |
de Souza et al. | Mass spectrometric characterization of two novel inflammatory peptides from the venom of the social wasp Polybia paulista | |
de Beukelaar et al. | The impact of impurities in synthetic peptides on the outcome of T‐cell stimulation assays | |
Landreh et al. | New developments in protein structure–function analysis by MS and use of hydrogen–deuterium exchange microfluidics |